Search Results 821-830 of 17090 for macronutrient balancing

  1. A Study of Acalabrutinib and Vistusertib in Subjects With Relapsed/Refractory B-cell Malignancies - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis - Mayo Clinic

    This first-in-human, double-blind, placebo-controlled Phase I study will be conducted in participants with amyotrophic lateral sclerosis (ALS) to explore safety ...

  3. A Study to Evaluate CC-98633 to Treat Subjects with Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

    Less differentiated T cells have shown an increased ability to proliferate, persist, and mediate responses in mouse tumor models compared to more differentiated ...

  4. Evaluation of the Spiration Valve for Emphysema to Improve Lung Function - Mayo Clinic

    About this study. This is a multicenter, prospective, randomized, controlled study designed to evaluate improvement of lung function after treatment with ...

  5. Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Subjects With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

    Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Subjects With Newly Diagnosed Stage III or IV, High-grade Serous, ...

  7. Shared Decision Making with Diabetic Patients - Mayo Clinic

    About this study. This research study is being done to develop educational materials that will help patients and clinicians talk about diabetes treatment ...

  8. Study of SBP-101 in Pancreatic Cancer - Clinical Trials

    This phase 1 first-in-human study evaluates safety and tolerability of SBP-101 in subjects with previously treated pancreatic ductal adenocarcinoma and will ...

  9. Meng Welliver, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    Dr. Welliver leads a multidisciplinary translational research program that integrates tumor genetic biomarkers, imaging-based biomarkers and patient-derived ...

  10. Cyclophosphamide, Ixazomib, and Dexamethasone in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma - Mayo Clinic

    Ixazomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving cyclophosphamide together with ixazomib and ...